Comirnaty JN.1

Medicinal product

(Invented) name

Comirnaty JN.1

Active substance (s)

COVID-19 mRNR vakcina. Bretovameranas

Strength

30 µg/dozėje

Pharmaceutical form

injekcinė dispersija užpildytame švirkšte

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J07BN01, covid-19, RNA-based vaccine

Marketing authorisation holder

BioNTech Manufacturing GmbH, Vokietija

Date of authorisation

2020-12-21

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Dozėje (0,3 ml) yra	0.3 ml
COVID-19 mRNR vakcina. Bretovameranas	30 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
114200	100312	1100312	užpildytas švirkštas	N10 (10 dozių) (stiklinis)		Receptinis	EU/1/20/1528/030	Netiekiama	-	-	No	-	-
114201	100313	1100313	užpildytas švirkštas	N10 (10 dozių) (plastikinis)		Receptinis	EU/1/20/1528/031	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-12-21	Registruotas